The University of California San Diego has been named the globe’s 16th best university by U.S. News and World Report. The campus was also recognized as the nation’s 5th best public university in the fourth annual rankings, which measure factors such as research, global and regional reputation; international collaboration; as well as the number of highly-cited papers and doctorates awarded.
Analyzing samples from a prospective study, University of California San Diego School of Medicine researchers found that human exposure to glyphosate, a chemical widely found in weed killers, has increased approximately 500 percent since the introduction of genetically modified crops.
A study by UC San Diego biologists uncovered a new mechanism linking a human gene’s function to chronic inflammation and cancer. Through large-scale genomic analyses, they discovered that “mutant p53” amplifies the impact of inflammation, leading to increases in cancer. Thus, rather than fighting tumor growth, mutant forms of p53 appear to be tapping into the body’s immune response system to fuel pro-inflammatory responses that increase cancer growth.
The University of California San Diego’s commitment to reducing energy use recently garnered the campus a first place award in the North American Laboratory Freezer Challenge. The nationwide best practice competition encourages laboratories to reduce the environmental and financial costs of ultra-low temperature freezers.
University of California San Diego anthropology professor Thomas E. Levy is back in San Diego after participating in the fourth International Conference on Dialogue of Civilizations, held in Ahmedabad, India and co-organized by the National Geographic Society (NGS), Archaeological Survey of India (ASI) and India’s Ministry of Culture.
University of California San Diego researchers have developed the first 3D spatial visualization tool for mapping “’omics” data onto whole organs. The tool helps researchers and clinicians understand the effects of chemicals, such as microbial metabolites and medications, on a diseased organ in the context of microbes that also inhabit the region. The work could advance targeted drug delivery for cystic fibrosis and other conditions where medications are unable to penetrate.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
